About Merck
EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, employing over 1,200 individuals around the country with U.S. headquarters located in Rockland, Massachusetts. The company develops and offers therapies for specialty-care conditions, like multiple sclerosis, infertility and cancer. EMD Serono is committed to transforming lives by developing therapies that patients need and providing industry-leading educational and support programs.
Advertisement
Product portfolio of Merck
Similar companies
News about Merck
Here you will find EMD Serono, Inc.
Last viewed contents
World's first confocal light microscope to study chiral molecules - This discovery is a major breakthrough that will allow researchers to analyse previously unexplored parts of biology and chemistry
Y chromosome of horses reveals the global triumph of Oriental stallions - “Our study shows that MSY analysis can uncover the complex history of horse breeds”
A giant called MIMAS in the cell power plants - Mega protein complex with surprising properties discovered in mitochondria
Surface Measurement Systems Limited - Alperton, Middlesex, United Kingdom
Glycotope Winner at STEP Award 2010
Avita Medical Announces Issuance of a New U.S. Patent for ReCell
Michael Schreiber becomes second Managing Director of LUMITOS - The internationally experienced marketing executive joins LUMITOS from Mettler-Toledo
Advanced Cyclone Systems S A - Porto, Portugal
Nanobiotix Starts Clinical Trial with Lead Product NBTXR3 - A Completely New Cancer Treatment to Be Tested in Patients with Soft Tissue Sarcoma
GlycoVaxyn’s First Clinical Study with Bioconjugate Vaccine Initiated - Study to Evaluate Safety, Reactogenicity and Immunogenicity of Vaccine Against Shigella dysenteriae
Researchers develop molecular traps to target SARS-CoV-2 - Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells